Market News & Trends
Acumen Pharmaceuticals Presents In Vitro Human Neuron Model for Evaluating Binding of Amyloid Beta Oligomers in Alzheimer’s Disease
Acumen Pharmaceuticals, Inc. has recently demonstrated the utility of a human in vitro model of iPSC-derived excitatory neurons for a better understanding of which forms…
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People With Chronic Hepatitis B
Vaccitech plc recently announced positive topline final data from the HBV002 study (NCT04778904), a Phase 1b/2a clinical trial of VTP-300 in people with chronic Hepatitis…
Cyclerion Therapeutics Receives Orphan Drug Designation for the Treatment of Mitochondrial Diseases
Cyclerion Therapeutics, Inc. recently announced the US FDA has granted orphan drug designation to zagociguat (previously CY6463) for the treatment of mitochondrial diseases. Zagociguat is the first….
Cullinan Oncology Announces FDA Clearance of INDA for Novel Fusion Protein Harnessing IL-2 & IL-12 Cytokines
Cullinan Oncology, Inc. recently announced the US FDA has cleared its Investigational New Drug (IND) application for CLN-617, a fusion protein composed of two potent…
Jounce Therapeutics to be Acquired by Concentra Biosciences
Jounce Therapeutics, Inc. recently announced it has entered into a definitive merger agreement whereby Concentra Biosciences, LLC (Concentra) will acquire Jounce for $1.85 in cash per share plus….
Kala Pharmaceuticals Announces Positive Safety Update From Cohort 1 of Phase 2b Clinical Trial
Kala Pharmaceuticals, Inc. recently announced positive safety data from the first cohort of the CHASE (Corneal Healing After SEcretome therapy) Phase 2b clinical trial evaluating…
Macomics & Ono Pharmaceutical Partner to Discover & Develop Macrophage-Targeting Antibody Therapy for Cancer Treatment
Macomics Ltd recently announced it has entered into a worldwide drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. to develop new immuno-oncology antibody drugs…
Arch Biopartners Receives Funding for Development of LSALT Peptide Drug Program
Arch Biopartners Inc. recently announced it is receiving advisory services and up to $4 million in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the….
Harm Reduction Therapeutics & Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray to Reverse Opioid Overdoses
Harm Reduction Therapeutics and Catalent recently announced the signing of a commercial supply agreement. Under its terms, Catalent will manufacture Harm Reduction Therapeutics’ naloxone nasal…
Hovione & Laxxon Medical Establish Agreement for cGMP Production of 3D Screen-Printed Pharmaceutical Applications
Hovione and Laxxon Medical recently announced a strategic collaboration to advance the use of 3D screen-printing technologies for the pharmaceutical industry. This partnership combines Laxxon's…
Visus Therapeutics Completes Enrollment in Phase 3 Clinical Trial for the Treatment of Presbyopia
Visus Therapeutics Inc. recently announced it has completed patient enrollment and the last visit had been conducted in BRIO-I, a pivotal Phase 3 trial for…
Bio-Rad Launches PTC Tempo 96 & PTC Tempo Deepwell Thermal Cyclers
Bio-Rad Laboratories, Inc. recently announced the launch of its PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers, designed to optimize PCR applications, such as…
Woodstock Sterile Solutions Completes Analytical Lab Expansion, Becomes One-Stop Shop CDMO
Woodstock Sterile Solutions has recently completed an expansion of its quality control analytical laboratory at its production facility in Woodstock, IL. The larger laboratory accommodates…
Adare Pharma Solutions Selects Vantage to Lead Major Packaging Facility Upgrade
Adare Pharma Solutions recently announced it has selected Vantage Solutions to lead a major upgrade of their pharmaceutical packaging capabilities. Vantage’s upgrades will allow Adare…
Scorpius BioManufacturing Announces the Appointment of Gary Welch as Interim President
[caption id="attachment_137699" align="alignleft" width="150"] Gary Welch[/caption] Scorpius BioManufacturing recently announced the appointment of Gary Welch as Interim President. With a career spanning more than 30…
Stevanato Group Collaborates With Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market
The companies will offer an integrated device and fill-and-finish solution to streamline the management of the pharmaceutical supply chain….
Halberd Eradicates All Strains of Antibiotic-Resistant E. Coli Provided by the CDC at Youngstown State University
Halberd Corporation recently reported it has successfully eradicated all of the strains of antibiotic-resistant E. coli samples previously provided by the CDC. Using Halberd’s patented…
Pharmaceutics International, Inc. Onboards New Leadership Team to Drive Quality, Operational Improvements & Growth
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), recently announced the formation of a new leadership team whose strengths and dedication to…
Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia
Vaxxinity, Inc. recently announced the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 clinical trial of VXX-401, an investigational vaccine designed to lower low-density lipoprotein….
Allarity Therapeutics Doses First Patient in Phase 1b Clinical Trial Evaluating Dovitinib & Stenoparib Combination in Advanced Solid Tumors
Allarity Therapeutics, Inc. recently announced it has dosed the first patient in a Phase 1b clinical study evaluating the combination of stenoparib and dovitinib for…
